Compare
Up to four compounds, side by side.
Useful for choosing between similar peptides or planning a stack.
Add a peptide
| Attribute | Nootropic Peptide Dihexa |
|---|---|
| Summary | Orally active synaptogenic compound — promising preclinical cognition data. |
| Mechanism | Small angiotensin IV analog that activates HGF/c-Met to drive synaptogenesis. |
| Top outcomes |
|
| Evidence | anecdotal |
| Half-life | Unclear in humans |
| Administration | oral |
| Legal status | research only |
| Safety | Theoretical concerns around uncontrolled growth (HGF signaling). |